Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An announcement from Biome Australia Ltd ( (AU:BIO) ) is now available.
Biome Australia has applied to the ASX for quotation of 2,488,743 new ordinary fully paid shares, issued on 19 March 2026. The shares were issued under an employee incentive scheme and will be quoted on the market, indicating ongoing use of equity-based remuneration to reward and motivate employees while modestly increasing the company’s free float and capital structure complexity.
The application, lodged as a new announcement under Appendix 2A of the ASX Listing Rules, confirms that these securities are either not subject to transfer restrictions or will be quoted despite such restrictions. For investors, the move underscores Biome Australia’s reliance on share-based incentives as part of its compensation strategy, with a limited but notable dilutive effect on existing shareholders.
The most recent analyst rating on (AU:BIO) stock is a Hold with a A$0.38 price target. To see the full list of analyst forecasts on Biome Australia Ltd stock, see the AU:BIO Stock Forecast page.
More about Biome Australia Ltd
Biome Australia Ltd is an ASX-listed company in the healthcare and life sciences sector. It operates under the ticker BIO and issues ordinary fully paid shares, with securities that can be used in employee incentive schemes to support staff retention and alignment with shareholder interests.
Average Trading Volume: 257,805
Technical Sentiment Signal: Hold
Current Market Cap: A$81.94M
Learn more about BIO stock on TipRanks’ Stock Analysis page.

